At Click World 2023 in Las Vegas, Randy Krauss, the executive director at Merck & Co., shared insights into the role of Metrics, Analytics, and Performance within the global clinical trial operations group. In this blog post, we’ll dive into the journey of implementing Qlik within Merck & Co. and the impact it has had on the organization.

The Qlik Journey at Merck & Co.

Use Cases Addressed with Qlik

• Qlik has enabled Merck & Co. to aggregate data from multiple sources and create stories for end users.
• The platform provides insights to support decision-making across the organization’s portfolio and day-to-day operations.

The Lead Up to Implementing Qlik

• Merck & Co. recognized the need for a tool to bring in data from various sources and provide valuable insights to support operational processes.
• The organization had to identify the data needed from different sources and work with customers to develop business questions and storytelling.

Forming a Relationship with Qlik

• Randy Krauss had prior experience with Qlik before joining Merck & Co.
• Qlik was already working with other groups within the organization, making it a natural choice to partner with them.

Key Steps in the Implementation Journey

• The Qlik journey at Merck & Co. began in 2019, focusing on data ingestion and working with customers to develop business questions.
• The organization also focused on aggregating data and selecting visuals to tell compelling stories for end users.

Overcoming Challenges and Achieving Success

Addressing Data Literacy

• Merck & Co. is actively working on improving data literacy within the organization.
• The organization is providing basic data literacy training and creating role-based and object-based training paths to empower employees.

Overcoming Blockers

• Time was a significant blocker, as employees were already busy with training plans and compliance requirements.
• Merck & Co. had to demonstrate the value of investing time in learning the new tools and show quick wins to encourage adoption.

Quick Wins and Future Roadmap

• The ability to centralize information and provide aggregated insights has been a quick win for users at Merck & Co.
• The organization is evolving into more advanced analytics, harnessing the power of data to drive decisions and support clinical trials.

Embracing Cloud Adoption

• Merck & Co. is in the learning phase of cloud adoption, focusing on dashboards, reports, and exploring AI-driven analytics.
• The organization is excited about the potential to leverage cloud technologies to further enhance decision-making and operational processes.

A Rewarding Journey

• Randy Krauss highlighted the rewarding aspect of supporting teams and seeing the impact of the tools created at Merck & Co.
• The ultimate reward lies in the ability to bring clinical studies to a close earlier, potentially expediting the delivery of life-saving treatments and vaccines.

As Randy Krauss shared his insights at Click World 2023, it’s evident that the journey of implementing Qlik at Merck & Co. has been transformative. The organization has overcome challenges, achieved quick wins, and is now focused on leveraging advanced analytics and cloud technologies to drive impactful decisions and save lives.

Stay tuned for more updates on the transformative journey of data analytics at Merck & Co.!

Conclusion

The implementation of Qlik at Merck & Co. has been a journey of overcoming challenges, achieving quick wins, and embracing advanced analytics and cloud technologies. The organization’s commitment to data literacy and empowering employees has paved the way for impactful decision-making and potentially life-saving outcomes. As Randy Krauss shared his insights at Click World 2023, it’s evident that the journey of implementing Qlik at Merck & Co. has been transformative. The organization has overcome challenges, achieved quick wins, and is now focused on leveraging advanced analytics and cloud technologies to drive impactful decisions and save lives. Stay tuned for more updates on the transformative journey of data analytics at Merck & Co.!